Modulation of carnitine palmitoyltransferase-1 for the treatment of obesity

Area of Science:

• Biochemistry
• Metabolic Disorders
• Pharmacology

Background:

• Obesity is a growing global health concern, characterized by disrupted energy metabolism.
• Pharmacological interventions are sought to increase energy expenditure or decrease appetite.
• The fatty acid oxidation pathway, particularly carnitine palmitoyltransferase (CPT)-1, is a key metabolic target.

Purpose of the Study:

• To review the dual role of carnitine palmitoyltransferase (CPT)-1 in obesity.
• To discuss strategies involving both CPT-1 inhibition and enhancement for obesity therapy.
• To explore the potential of CPT-1 modulation for managing energy metabolism and food intake.

Main Methods:

• Literature review of existing data on CPT-1 activity.
• Analysis of studies investigating CPT-1 inhibition for obesity.
• Examination of research on CPT-1 enhancement strategies for obesity.

Main Results:

• CPT-1 activity is a critical factor in regulating fatty acid oxidation.
• Both inhibition and enhancement of CPT-1 show potential for obesity treatment.
• Modulating CPT-1 may offer a dual approach to managing energy balance and appetite.

Conclusions:

• Carnitine palmitoyltransferase (CPT)-1 is a promising target for novel obesity pharmacotherapies.
• Further research into the 'CPT-1 activity balance' is crucial for developing effective obesity treatments.
• Targeting CPT-1 offers a potential pathway for simultaneous regulation of energy expenditure and food intake.